Business Description
CeriBell Inc
NAICS : 325413
SIC : 3845
ISIN : US15678C1027
Total Employee Number:
300Description
CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 6.38 | |||||
Equity-to-Asset | 0.79 | |||||
Debt-to-Equity | 0.16 | |||||
Debt-to-EBITDA | -0.39 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 10.59 | |||||
Beneish M-Score | -2.53 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 29.9 | |||||
3-Year EBITDA Growth Rate | 3 | |||||
3-Year EPS without NRI Growth Rate | 2.7 | |||||
3-Year FCF Growth Rate | 6.5 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 18.48 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 28.03 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 51.95 | |||||
9-Day RSI | 55.54 | |||||
14-Day RSI | 55.12 | |||||
3-1 Month Momentum % | 1.27 | |||||
6-1 Month Momentum % | -21.22 | |||||
12-1 Month Momentum % | 9.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 10.44 | |||||
Quick Ratio | 10.01 | |||||
Cash Ratio | 8.72 | |||||
Days Inventory | 204.85 | |||||
Days Sales Outstanding | 51.15 | |||||
Days Payable | 67.59 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.3 | |||||
Shareholder Yield % | 0.03 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 87.72 | |||||
Operating Margin % | -68.31 | |||||
Net Margin % | -63.51 | |||||
EBITDA Margin % | -60.25 | |||||
FCF Margin % | -52.61 | |||||
OCF Margin % | -51.23 | |||||
ROE % | -37.12 | |||||
ROA % | -30.35 | |||||
ROIC % | -272.06 | |||||
3-Year ROIIC % | -184.59 | |||||
ROC (Joel Greenblatt) % | -410.06 | |||||
ROCE % | -31.9 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 7.63 | |||||
PB Ratio | 5.26 | |||||
Price-to-Tangible-Book | 5.26 | |||||
EV-to-EBIT | -10.65 | |||||
EV-to-EBITDA | -10.88 | |||||
EV-to-Revenue | 6.55 | |||||
EV-to-Forward-Revenue | 5.45 | |||||
EV-to-FCF | -12.46 | |||||
| Price-to-Net-Current-Asset-Value | 5.63 | |||||
| Price-to-Net-Cash | 7.15 | |||||
Earnings Yield (Greenblatt) % | -9.39 | |||||
FCF Yield % | -6.74 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CBLL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
CeriBell Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 95.066 | ||
| EPS (TTM) ($) | -1.63 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 69.21 | ||
| 14-Day RSI | 55.12 | ||
| 14-Day ATR ($) | 0.764943 | ||
| 20-Day SMA ($) | 19.0275 | ||
| 12-1 Month Momentum % | 9.67 | ||
| 52-Week Range ($) | 10.85 - 24.33 | ||
| Shares Outstanding (Mil) | 37.94 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
CeriBell Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
CeriBell Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-04 16:30 | In 117 days | ||
| Third quarter earnings results for 2026 | 2026-11-04 | In 116 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-05 16:30 | In 26 days | ||
| Second quarter earnings results for 2026 | 2026-08-05 | In 25 days | ||
| William Blair 46th Annual Growth Stock Conference | 2026-06-03 09:20 | 17.50 (+0.57%) | ||
| General meeting for 2026 | 2026-06-02 09:00 | 17.61 (-4.29%) | ||
| Guidance call for 2026 | 2026-05-13 18:40 | 16.75 (-9.65%) | ||
| First quarter earnings conference call for 2026 | 2026-05-11 16:30 | 20.20 (-0.83%) | ||
| First quarter earnings results for 2026 | 2026-05-11 | 20.20 (-0.83%) | ||
| TD Cowen 46th Annual Health Care Conference | 2026-03-03 13:50 | 18.16 (+0.11%) |
Show
Entries
CeriBell Inc Frequently Asked Questions
What is CeriBell Inc(CBLL)'s stock price today?
The current price of CBLL is $19.58. The 52 week high of CBLL is $24.33 and 52 week low is $10.85.
When is next earnings date of CeriBell Inc(CBLL)?
The next earnings date of CeriBell Inc(CBLL) is 2026-08-05 Est..
Does CeriBell Inc(CBLL) pay dividends? If so, how much?
CeriBell Inc(CBLL) does not pay dividend.
Guru Commentaries on NAS:CBLL
No articles.
Press Release
Articles on CeriBell Inc
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers